# Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

> **NCT01466244** · — · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 42 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **DRUG:** cisplatin
- **GENETIC:** gene expression analysis
- **GENETIC:** microarray analysis
- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01466244
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-11
- **Primary completion:** 2012-01-11
- **Final completion:** 2012-01-11
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2017-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466244, "Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01466244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*